S

Surgical Science Sweden AB
OTC:SUSRF

Watchlist Manager
Surgical Science Sweden AB
OTC:SUSRF
Watchlist
Price: 3.41 USD Market Closed
Market Cap: $174m

Wall Street
Price Targets

SUSRF Price Targets Summary
Surgical Science Sweden AB

Wall Street analysts forecast SUSRF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SUSRF is 9.68 USD with a low forecast of 5.52 USD and a high forecast of 16.93 USD.

Lowest
Price Target
5.52 USD
62% Upside
Average
Price Target
9.68 USD
184% Upside
Highest
Price Target
16.93 USD
396% Upside
Surgical Science Sweden AB Competitors:
Price Targets
CBAN
Colony Bankcorp Inc
3% Upside

Revenue
Forecast

39% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
39% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 9 years the compound annual growth rate for Surgical Science Sweden AB's revenue is 39%. The projected CAGR for the next 4 years is 21%.

Operating Income
Forecast

63% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss
63% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss

For the last 9 years the compound annual growth rate for Surgical Science Sweden AB's operating income is 63%. The projected CAGR for the next 4 years is 44%.

Net Income
Forecast

63% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
63% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

For the last 9 years the compound annual growth rate for Surgical Science Sweden AB's net income is 63%. The projected CAGR for the next 4 years is 40%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SUSRF's stock price target?
Price Target
9.68 USD

According to Wall Street analysts, the average 1-year price target for SUSRF is 9.68 USD with a low forecast of 5.52 USD and a high forecast of 16.93 USD.

What is Surgical Science Sweden AB's Revenue forecast?
Projected CAGR
21%

For the last 9 years the compound annual growth rate for Surgical Science Sweden AB's revenue is 39%. The projected CAGR for the next 4 years is 21%.

What is Surgical Science Sweden AB's Operating Income forecast?
Projected CAGR
44%

For the last 9 years the compound annual growth rate for Surgical Science Sweden AB's operating income is 63%. The projected CAGR for the next 4 years is 44%.

What is Surgical Science Sweden AB's Net Income forecast?
Projected CAGR
40%

For the last 9 years the compound annual growth rate for Surgical Science Sweden AB's net income is 63%. The projected CAGR for the next 4 years is 40%.

Back to Top